Clinical Trials Directory

Trials / Completed

CompletedNCT02991729

Use of a Novel Computerized Decision Aid for Prenatal Aneuploidy Screening

Use of a Novel Decision Aid for Prenatal Aneuploidy Screening

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
197 (actual)
Sponsor
University of North Carolina, Chapel Hill · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The investigators aim to assess whether use of a novel, tablet-based computerized decision aid for aneuploidy screening is similar to routine care with a brief genetic counseling visit in improving patient knowledge and decreasing decisional conflict.

Detailed description

184 women will be randomized in a 1:1 fashion to use of a novel computerized iPad-based decision aid in addition to routine counseling or routine counseling only during a single study visit. This decision aid was developed at a 10th grade literacy level using input from Maternal Fetal Medicine physicians and certified genetic counselors, and piloted by 20 English and Spanish speaking women of varying education levels. Following completion of genetic counseling, participants will complete several surveys assessing knowledge and decision conflict. Data will be abstracted regarding demographics, screening and diagnostic testing uptake, and testing results.

Conditions

Interventions

TypeNameDescription
OTHERiPad-based decision aidThis is a novel decision aid developed by genetic counselors and Maternal Fetal Medicine physicians. It is used via an iPad and is interactive. It is available in English and Spanish has been piloted by 20 English and Spanish speaking women. It takes approximately 15 minutes to complete.
OTHERGenetic counseling appointmentAll participants will undergo an approximately 15 minute educational genetic counseling appointment regarding aneuploidy screening options. Should family history concerns be identified on intake, this visit may be extended to include a discussion of additional issues.

Timeline

Start date
2017-01-20
Primary completion
2018-01-05
Completion
2018-01-12
First posted
2016-12-13
Last updated
2020-10-22
Results posted
2019-11-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02991729. Inclusion in this directory is not an endorsement.